Genscript Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	142.49	131.99	1,446	1,024	1,181
Short-Term Investments	169.79	264.37	376.22	228.89	222.53
Trading Asset Securities	499.71	224.87	105.3	210.82	2.21
Cash & Short-Term Investments	811.99	621.24	1,928	1,464	1,406
Cash Growth	30.70%	-67.78%	31.71%	4.13%	82.00%
Accounts Receivable	133.93	116.29	218.83	104.28	142.44
Other Receivables	-	19.84	80.66	66.13	22.46
Receivables	133.93	136.13	299.53	170.44	166.58
Inventory	39.59	31.1	53.35	59.94	44.36
Prepaid Expenses	-	2.93	1.99	2.13	5.48
Restricted Cash	31.13	17.92	33.07	27.2	1.44
Other Current Assets	62.32	25.67	37.25	41.53	15.49
Total Current Assets	1,079	834.98	2,353	1,765	1,639
Property, Plant & Equipment	612.69	595.62	728.73	624.67	486.91
Long-Term Investments	3,111	3,790	85.41	16.03	18.47
Goodwill	1.37	1.34	1.36	2.55	14.15
Other Intangible Assets	13.25	13.04	18.65	23.81	26.42
Long-Term Accounts Receivable	-	-	0.29	0.4	-
Long-Term Deferred Tax Assets	16.44	27.74	16.51	15.05	5.09
Other Long-Term Assets	19.88	15.81	183.26	98.93	43.77
Total Assets	4,853	5,278	3,387	2,546	2,234
Accounts Payable	36.79	29.84	39.96	55.76	30.18
Accrued Expenses	83.1	69.86	164.77	210.03	156.11
Short-Term Debt	194.67	88.75	56.94	33.23	-
Current Portion of Long-Term Debt	-	-	0.07	0.45	0.52
Current Portion of Leases	9.16	7.52	8.87	11.1	7.51
Current Income Taxes Payable	28.69	9.39	18.13	16.15	15.72
Current Unearned Revenue	50.32	47.36	98.58	44.33	35.47
Other Current Liabilities	317.45	54.63	107.49	174.93	167.79
Total Current Liabilities	720.17	307.34	494.81	545.98	413.31
Long-Term Debt	85.93	570.48	712.72	567.23	381.86
Long-Term Leases	55.01	56.99	63.91	44.01	27.35
Long-Term Unearned Revenue	12.17	13.03	64.68	2.01	15.54
Long-Term Deferred Tax Liabilities	14.01	5.84	5.62	8.01	7.73
Other Long-Term Liabilities	1.3	1.24	1.21	16.48	0.4
Total Liabilities	888.59	954.91	1,343	1,184	846.18
Common Stock	2.19	2.14	2.12	2.11	2.1
Additional Paid-In Capital	-	1,982	1,939	1,473	1,274
Retained Earnings	-	2,364	-597.73	-502.25	-275.4
Treasury Stock	-3.83	-6.09	-9.45	-11.92	-15.75
Comprehensive Income & Other	3,961	-20.56	56.87	49.57	60.78
Total Common Equity	3,959	4,321	1,391	1,011	1,046
Minority Interest	5.36	2.19	653.28	352.13	341.7
Shareholders' Equity	3,965	4,323	2,044	1,363	1,388
Total Liabilities & Equity	4,853	5,278	3,387	2,546	2,234
Total Debt	344.77	723.74	842.5	656.02	417.24
Net Cash (Debt)	467.22	-102.5	1,085	807.69	988.47
Net Cash Growth	-	-	34.38%	-18.29%	37.79%
Net Cash Per Share	0.22	-0.05	0.51	0.39	0.49
Filing Date Shares Outstanding	2,180	2,160	2,124	2,111	2,096
Total Common Shares Outstanding	2,180	2,144	2,123	2,111	2,096
Working Capital	358.8	527.64	1,858	1,219	1,226
Book Value Per Share	1.82	2.02	0.66	0.48	0.50
Tangible Book Value	3,945	4,307	1,371	984.18	1,005
Tangible Book Value Per Share	1.81	2.01	0.65	0.47	0.48
Land	390.96	320.67	350.49	265.52	188.58
Machinery	380.53	311.68	319.62	257.2	224.78
Construction In Progress	63.59	129.37	131.6	142.06	91.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.